Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/982045728
总结
CYP2C9 *1/*3 is associated with decreased warfarin dose in Korean patients with mechanical heart valve replacement since day 7 of warfarin therapy when treated with warfarin as compared to CYP2C9 *1/*1.